Share
𝕏 Facebook LinkedIn

Histologic evaluation of thermal capsulorrhaphy of human shoulder joint capsule with monopolar radiofrequency energy during short- to long-term follow-up.

PAPER pubmed Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 2008 Case-control study Effect: mixed Evidence: Low

Abstract

PURPOSE: The purpose of this study was to evaluate the histologic morphology of human shoulder joint capsule after thermal capsulorrhaphy with monopolar radiofrequency energy (mRFE) during short- to long-term follow-up. METHODS: This study comprised 27 patients who received an arthroscopic mRFE thermal capsulorrhaphy and 10 patients without mRFE treatment serving as the control group. Biopsy samples from 3 locations (anterior-superior, anterior-inferior, and posterior-medial) of the shoulder joint capsule were harvested from both the mRFE-treated patients and the control patients. The follow-up time for the mRFE treatment ranged from 3.5 to 62 months, which was divided into 3 groups: short, 3.5 to 12 months; medium, 14 to 25 months; and long, 31 to 62 months. The biopsy samples were analyzed via a histologic scoring system, evaluating an intact synovial layer, subsynovial edema, collagen morphology, cellularity, vascularity, and inflammatory cells. Histologic scores among each follow-up group were compared with each other and with those in the control group. RESULTS: There were no significant differences in the histologic categories of intact synovial layer, subsynovial edema, collagen morphology, and inflammatory cells among the control and mid- and long-term mRFE groups. The short-term mRFE group had greater increased cellularity and vascularity compared with the mid- and long-term groups, which progressively improved toward the appearance in the normal control group with time. CONCLUSIONS: After mRFE capsulorrhaphy, histologic analysis revealed that the mRFE-treated shoulder joint capsule had almost returned to normal, except for persistent cellularity and increased vascularity, which were present at up to 5 years after this procedure. LEVEL OF EVIDENCE: Level III, therapeutic case-control study.

AI evidence extraction

At a glance
Study type
Case-control study
Effect direction
mixed
Population
Human patients undergoing shoulder joint capsule biopsy after arthroscopic mRFE thermal capsulorrhaphy; controls without mRFE treatment
Sample size
37
Exposure
monopolar radiofrequency energy (mRFE) used for arthroscopic thermal capsulorrhaphy · follow-up 3.5 to 62 months (short 3.5–12; medium 14–25; long 31–62 months)
Evidence strength
Low
Confidence: 78% · Peer-reviewed: yes

Main findings

No significant differences were reported for intact synovial layer, subsynovial edema, collagen morphology, and inflammatory cells between controls and mid-/long-term mRFE groups. The short-term mRFE group showed increased cellularity and vascularity versus mid-/long-term groups, with progressive improvement toward control appearance over time; conclusions note persistent cellularity and increased vascularity up to 5 years.

Outcomes measured

  • Histologic morphology/scoring of shoulder joint capsule (intact synovial layer, subsynovial edema, collagen morphology, cellularity, vascularity, inflammatory cells)

Limitations

  • Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported in abstract
  • Therapeutic case-control design (Level III)
  • Histologic outcomes only; clinical outcomes not described in abstract

Suggested hubs

  • other (0.2)
    Medical/surgical therapeutic use of radiofrequency energy rather than environmental/consumer EMF exposure
View raw extracted JSON
{
    "study_type": "case_control",
    "exposure": {
        "band": null,
        "source": "monopolar radiofrequency energy (mRFE) used for arthroscopic thermal capsulorrhaphy",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "follow-up 3.5 to 62 months (short 3.5–12; medium 14–25; long 31–62 months)"
    },
    "population": "Human patients undergoing shoulder joint capsule biopsy after arthroscopic mRFE thermal capsulorrhaphy; controls without mRFE treatment",
    "sample_size": 37,
    "outcomes": [
        "Histologic morphology/scoring of shoulder joint capsule (intact synovial layer, subsynovial edema, collagen morphology, cellularity, vascularity, inflammatory cells)"
    ],
    "main_findings": "No significant differences were reported for intact synovial layer, subsynovial edema, collagen morphology, and inflammatory cells between controls and mid-/long-term mRFE groups. The short-term mRFE group showed increased cellularity and vascularity versus mid-/long-term groups, with progressive improvement toward control appearance over time; conclusions note persistent cellularity and increased vascularity up to 5 years.",
    "effect_direction": "mixed",
    "limitations": [
        "Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported in abstract",
        "Therapeutic case-control design (Level III)",
        "Histologic outcomes only; clinical outcomes not described in abstract"
    ],
    "evidence_strength": "low",
    "confidence": 0.7800000000000000266453525910037569701671600341796875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "monopolar radiofrequency energy",
        "thermal capsulorrhaphy",
        "shoulder joint capsule",
        "histology",
        "cellularity",
        "vascularity",
        "follow-up"
    ],
    "suggested_hubs": [
        {
            "slug": "other",
            "weight": 0.200000000000000011102230246251565404236316680908203125,
            "reason": "Medical/surgical therapeutic use of radiofrequency energy rather than environmental/consumer EMF exposure"
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.